To Evaluate the Drug-drug Interaction Between Telmisartan and Atorvastatin in Healthy Male Volunteers

Inclusion Criteria: * Healthy male subjects between the ages of 19 and 55 years * Subjects who don't have congenital or chronic diseases and have no abnormal medical examination results within 3 years * Healthy Subjects (no clinically relevant findings in any of the investigations of the pre-examination) as judged by the investigator * Subjects who signed and dated in informed consent form indicating that the subject has decided to participate in the study after being informed of all pertinent aspects of the study * Subjects who are willing and able to comply with all scheduled visits, treatment plan, laboratory tests, and other study procedures Exclusion Criteria: * Evidence or history of clinically significant hematological, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric, neurologic, or allergic disease (but excluding untreated, asymptomatic, seasonal allergies at time of dosing) * Any condition possibly affecting drug absorption, distribution, metabolism, and excretion (e.g. gastrectomy) * Twofold or more than upper limit of normal range in laboratory test for ALT or AST * Participating in other clinical trial study within 2 month preceding the first dose of investigational product * History of significant alcohol abuse or drug abuse within one year prior to the screening * Whole blood donation within 2 months prior to dosing, or apheresis donation within 1 month prior to dosing * Other severe acute or chronic medical or psychiatric …